Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Terminated Phase 3 Interventional Results available

Assessment of Efficacy and Safety of Ruxolitinib in Participants With COVID-19-Associated ARDS Who Require Mechanical Ventilation (RUXCOVID-DEVENT)

ClinicalTrials.gov ID: NCT04377620

Public ClinicalTrials.gov record NCT04377620. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 22, 2026, 2:23 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Assess the Efficacy and Safety of Ruxolitinib in Participants With COVID-19-Associated ARDS Who Require Mechanical Ventilation (RUXCOVID-DEVENT)

Study identification

NCT ID
NCT04377620
Recruitment status
Terminated
Study type
Interventional
Phase
Phase 3
Lead sponsor
Incyte Corporation
Industry
Enrollment
211 participants

Conditions and interventions

Conditions

Interventions

  • Placebo Drug
  • Ruxolitinib Drug

Drug

Eligibility (public fields only)

Age range
12 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
May 23, 2020
Primary completion
Feb 25, 2021
Completion
Feb 25, 2021
Last update posted
Jan 18, 2022

2020 – 2021

United States locations

U.S. sites
35
U.S. states
19
U.S. cities
32
Facility City State ZIP Site status
Honor Health Research Institute Scottsdale Arizona 85258
Sharp Memorial Hospital San Diego California 92123
Georgetown University Hospital Washington D.C. District of Columbia 20007
Teradan Clinical Trials Brandon Florida 33511
University of Florida Gainesville Florida 32610
Tampa General Hospital Tampa Florida 33606
University of South Florida Tampa Florida 33613
Northshore University Health System Chicago Illinois 60678
Loyola University Medical Center Maywood Illinois 60153
Indiana University Simon Cancer Center Indianapolis Indiana 46202
Indiana University Health Central Indiana Cancer Centers Indianapolis Indiana 46219
East Jefferson General Hospital Metairie Louisiana 70006
Johns Hopkins University Baltimore Maryland 21224
Boston Medical Center Boston Massachusetts 02118
Lahey Hospital & Medical Center Burlington Massachusetts 01805
University of Massachusetts Medical School Worcester Massachusetts 01655
Healthpartners Cancer Care Center - Regions Hospital Saint Paul Minnesota 55101
Mercy Research Springfield Missouri 65804
Hackensack University Medical Center Hackensack New Jersey 07601
Rutgers Njms Clinical Research Unit Newark New Jersey 07103
Holy Name Medical Center Teaneck New Jersey 07666
University of Rochester Medical Center Rochester New York 14642
Duke University Medical Center Durham North Carolina 27710
East Carolina University Greenville North Carolina 27858
University of Cincinnati Cincinnati Ohio 45219
Kettering Cancer Care Dayton Ohio 45429
Jefferson University Hospitals Philadelphia Pennsylvania 19107
Temple University Philadelphia Pennsylvania 19140
West Penn Hospital Pittsburgh Pennsylvania 15224
Allegheny Health Network Wexford Pennsylvania 15090
St David'S Medical Center Austin Texas 78705
University of Texas Health Science Center At Houston - McGovern Medical School Houston Texas 77030
University of Texas Health Science Cente San Antonio Texas 78229
Wenatchee Valley Hospital and Clinics Wenatchee Washington 98801
Aurora Research Institute Milwaukee Wisconsin 53233

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 1 non-U.S. site.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT04377620, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jan 18, 2022 · Synced Jul 22, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT04377620 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →